Luqi Cao, Yuhao Xie, Zhesheng Chen, Charles R Ashby
{"title":"一种环化络合物钌(II) Z (RuZ)克服了癌细胞在体外和体内的多药耐药:一个关键的突破。","authors":"Luqi Cao, Yuhao Xie, Zhesheng Chen, Charles R Ashby","doi":"10.2478/jtim-2023-0081","DOIUrl":null,"url":null,"abstract":"Multidrug resistance (MDR) is one of the major obstacles that attenuates or abrogates the efficacy of the treatment of cancer.[1] Previously, numerous studies have reported that certain metallo-complexed anticancer drugs, such as platinum (II)based compounds, are efficacious in treating specific types of cancer.[2] However, these compounds are not efficacious in MDR cancers. Consequently, there is a need for the synthesis and development of safe and efficacious metal-complexed anticancer drugs.","PeriodicalId":51339,"journal":{"name":"Journal of Translational Internal Medicine","volume":"11 2","pages":"95-97"},"PeriodicalIF":4.7000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318915/pdf/","citationCount":"0","resultStr":"{\"title\":\"A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes <i>in vitro</i> and <i>in vivo</i> multidrug resistance in cancer cells: A pivotal breakthrough.\",\"authors\":\"Luqi Cao, Yuhao Xie, Zhesheng Chen, Charles R Ashby\",\"doi\":\"10.2478/jtim-2023-0081\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Multidrug resistance (MDR) is one of the major obstacles that attenuates or abrogates the efficacy of the treatment of cancer.[1] Previously, numerous studies have reported that certain metallo-complexed anticancer drugs, such as platinum (II)based compounds, are efficacious in treating specific types of cancer.[2] However, these compounds are not efficacious in MDR cancers. Consequently, there is a need for the synthesis and development of safe and efficacious metal-complexed anticancer drugs.\",\"PeriodicalId\":51339,\"journal\":{\"name\":\"Journal of Translational Internal Medicine\",\"volume\":\"11 2\",\"pages\":\"95-97\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318915/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Translational Internal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2478/jtim-2023-0081\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Translational Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/jtim-2023-0081","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes in vitro and in vivo multidrug resistance in cancer cells: A pivotal breakthrough.
Multidrug resistance (MDR) is one of the major obstacles that attenuates or abrogates the efficacy of the treatment of cancer.[1] Previously, numerous studies have reported that certain metallo-complexed anticancer drugs, such as platinum (II)based compounds, are efficacious in treating specific types of cancer.[2] However, these compounds are not efficacious in MDR cancers. Consequently, there is a need for the synthesis and development of safe and efficacious metal-complexed anticancer drugs.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
